Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary pulmonary hypertension. Practical therapeutic recommendations.

L J Rubin1

  • 1Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore 21201.

Drugs
|January 1, 1992
PubMed
Summary

Primary pulmonary hypertension (PPH) is a rare, fatal condition. While no cure exists, vasodilator therapy and lung transplantation offer treatment options for patients with PPH.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A decade of achievement in pulmonary hypertension.

European respiratory review : an official journal of the European Respiratory Society·2011
Same author

Stabilization of meat lipids with nitrite-free curing mixtures.

Meat science·2011
Same author

Cardiovascular effects of pulmonary hypertension.

Trends in cardiovascular medicine·2011
Same author

Combining evidence and experience in pulmonary hypertension.

European respiratory review : an official journal of the European Respiratory Society·2010
Same author

Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis.

Arthritis and rheumatism·2010
Same author

Echocardiographic assessment of hemodynamic changes produced by two methods of inducing fluid deficit in dogs.

Journal of veterinary internal medicine·2010

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Research

Background:

  • Primary pulmonary hypertension (PPH) is a rare, progressive disease leading to right heart failure and death.
  • The exact cause of PPH remains unknown, highlighting the need for effective treatments.

Purpose of the Study:

  • To review current pharmacological and surgical treatment approaches for primary pulmonary hypertension.
  • To evaluate the efficacy of vasodilator therapy and transplantation in managing PPH.

Main Methods:

  • Review of pharmacological treatments, including oral calcium channel blockers and intravenous epoprostenol.
  • Analysis of surgical interventions, specifically combined heart-lung and single lung transplantation.

Main Results:

  • Vasodilator therapy provides sustained improvement in approximately two-thirds of PPH patients.
  • Intravenous epoprostenol is an option for refractory cases, serving as a bridge to transplantation.
  • Lung transplantation, particularly single lung, is a viable surgical option for select patients.

Conclusions:

  • While PPH lacks a cure, current treatments can significantly improve patient outcomes.
  • Treatment strategies should be individualized based on patient response and disease severity.

Related Experiment Videos